NEWS & PRESS RELEASES
Presentation of Saturn at NY Valves – June, 2026
At New York Valves 2026 InnovHeart brought three speakers: within the session "Innovations in TMVR", Dr. Paolo Denti from San Raffaele Hospital gave an overview of the Saturn Trans-septal TMVR System within the session "Mitral Interventions: TMVR with Novel Platforms...
Presentation of Saturn at CSI Frankfurt – June, 2026
Prof. Giedrius Davidavicius from VUL SK, Vilnius, presented the e-poster "Transseptal Transcatheter Mitral Valve replacement with a Saturn bioprosthesis" in the Structural and valvular interventions session at CSI Frankfurt on Thursday, Jun 4, 2026. Co-authors of the...
First-In-Human Trans-Septal Implantation of Saturn Mitral Valve Replacement
We are pleased to announce the first trans-septal clinical trial implant with our proprietary Saturn Transcatheter Mitral Valve. Excellent hemodynamic results are reported for the patient, a 79 year old female suffering from severe mixed (degenerative and functional)...
InnovHeart appoints David Wilson as Chief Executive Officer
Industry Leader to Guide Company and the Saturn TMVR Programin its Next Phase of Growth InnovHeart s.r.l. announced today the appointment of David James Wilson, an experienced healthcare and medical device executive as Chief Executive Officer of the company and...
“Learning and innovation go hand in hand.
The arrogance of success is to think that what you did yesterday
will be sufficient for tomorrow.”
William Pollard